Literature DB >> 7234706

Effect of lidocaine on escape rate in patients with complete atrioventricular block: B. Proximal His bundle block.

C S Kuo, C P Reddy.   

Abstract

Lidocaine was administered intravenously (a loading dose of 1.5 mg/kg body weight followed by a 3 mg/min infusion) to 10 patients with complete atrioventricular (A-V) block proximal to the His bundle and A-V junctional escape rhythm. A-V block was not due to an acute myocardial infarction in seven patients (group I) and was due to an acute inferior wall infarction in three patients (group II). Lidocaine had either no or only a slight depressant effect on the rate of the escape pacemaker in patients in group I but caused severe bradycardia or asystole in two of three patients in group II. Lidocaine had no consistent effect on the atrial rate and did not change the QRS duration and H-V intervals in any patient. These observations are consistent with the results of animal studies that showed that lidocaine selectively depressed conduction in ischemic or depolarized myocardium. The findings also suggest that the use of lidocaine without prior insertion of a pacemaker is unsafe in patients with acute myocardial infarction and complete A-V block proximal to the His bundle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7234706     DOI: 10.1016/0002-9149(81)90265-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Pitfalls and perils of intravenous lidocaine.

Authors:  C A Bryant; J R Hoffman; L S Nichter
Journal:  West J Med       Date:  1983-10

2.  The influence of hyperkalaemia on the cellular electrophysiology of lignocaine in cardiac tissue.

Authors:  B McGovern; M F Murnaghan
Journal:  Ir J Med Sci       Date:  1984-03       Impact factor: 1.568

3.  Postdefibrillation idioventricular rhythm--a salvageable condition.

Authors:  J R Hoffman; L W Stevenson
Journal:  West J Med       Date:  1987-02

4.  The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.

Authors:  G Stark; U Stark; E Pilger; K Hönigl; H Bertuch; H A Tritthart
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.